#2 Sustainable pharmaceutical Industry
July 2 | ENSIC, Université de Lorraine in Nancy, France
Featured Speakers
Edith Lecomte Norrant
CEO, IPSOMEDIC
“Industrial Relocation: Constraints and Methodology – A Case Study on Paracetamol”
More information
Successful International Director of multi-departments with more than 25 years of experience in Pharmaceutical industries. Leveraged creativity and collaborations to drive solutions and new technology for products with higher quality at lower cost in safety way while respecting the environment.
International Experience (Europe, USA, South America and Asia).
Project and Team Leader with experience in managing multiples teams and departments of up to 400 scientist and engineers. The management was done through scientific leadership, mentoring, accountability and credibility, and with a pragmatic vision, trust and integrity to build confident teams and move projects forward.
Disciplines: Innovation, R&D and Pilot, Plant manufacture for fine chemicals and API (Small & Large molecules)
Specialties: Chemical synthesis, Research, Biopharmaceutical manufacturing plants, New technologies implementation from R&D to plant manufacturing (Photo-reactions, Microwaves, Continuous Process from raw material to API, PAT, EBR (paperless), LES) under GMP conditions for small and large molecules.
Flavien Susanne
VP Chemical Development, Astrazeneca
“Factory of the future: how new manufacturing for the pharmaceutical industry will enable a sustainable industry”
David Moore
Senior Project Manager, Merck KGaA Darmstadt
“From Ideas to Impact: SMARTfacturing Capabilities that Enhance Sustainability and Lean Operations in the Chemical and Pharmaceutical Industry”
Other speakers
- Mark Barrett, AP Process
- Wouter Biesemans, VP Compliance, Ajinomoto
- Jean-Yves Lanne, Sanofi
- Michael Luescher, Novartis
- Dimitrios Meimaroglou, LRGP
- Lucrèce Nicoud, Ypso-Facto
- Laurence Pegon, Novasep-AXPLORA
- Mongi Sakly, Cabinet Sakly
- Céline Loubière, CNRS
- Marc Winter, Corning
PRE-PROGRAM
Shaping the Future: Risk Management, Impact Reduction, and Opportunity Creation
Date: 2 July 2025
Location: ENSIC, Université de Lorraine
🕘 Timing: 8:45 – 17:00
🍽 Lunch Break: 60 min
☕ Coffee Breaks: 2 × 30 min
📢 Sessions: 5
• 3 talks (35 min talk + 5 min Q&A)
• 7 presentations (20 min talk + 5 min Q&A)
08:30 : Accueil des participants
08:45 – Opening Speech
Jean-Pierre Dal Pont, SECF President
Isabelle Chevalot, LRGP co-director & Alain Durand – ENSIC
Session 1 : Engineering Innovations & the Future of Manufacturing
- 09:00 – 09:40 – Flavien Susanne, AstraZeneca
« Factory of the future: how new manufacturing for the pharmaceutical industry will enable a sustainable industry » - 09:40 – 10:30 – Edith Lecomte, ISPOMEDIC
« Industrial Relocation: Constraints and Methodology – A Case Study on Paracetamol »
10:30 – 10:50 Coffee break
Session 2 : Sustainability in Industrial Pharmacy
- 10:50 – 11:30 – David Moore, Merck KGaA
« From Ideas to Impact: SMARTfacturing Capabilities that Enhance Sustainability and Lean Operations in the Chemical and Pharmaceutical Industry » - 11:30 – 11:55 – Michael Luescher, Novartis
«Data driven decision making towards sustainable process development » - 11:55 – 12:20 – Mongi Sakly, Cabinet Sakly
« Reverse Engineering a new approach to efficient and innovative project management – Case study ; Clean Rooms » - 12:20 – 12:45 – Wouter Biesemans, Ajinomoto
« CDMO as a sustainable partner in the Net-Zero journey»
12:45 – 13:50 – Lunch break
Session 3 : Process Improvement & Intensification
Advanced separation technologies
- 13:50 – 14:15 – Laurence Pegon, Novasep-AXPLORA
« Dare to use preparative chromatography at industrial scale for your API »
Process/reaction modelling et simulation
- 14:15 – 14:40 – Lucrèce Nicoud, Ypso-Facto
« Towards Greener TIDES Production using Mechanistic Modeling » - 14:40 – 15:05 – Marc Winter, Corning
« Enabling Scalable Process Intensification through Flow Chemistry: Insights from Industrial Cases » - 15:05 – 15:30 – Céline Loubière, CNRS
Presentation of industrial integrator MTInov, This platform for studying, optimizing and scaling up the production of cell-based biomedicines, boasts expertise in cell culture in stirred bioreactors (on-line monitoring, intensification, bioreactor modeling and design), as well as in transfer to clinical grade in compliance with Good Manufacturing Practices (GMP).
15:30 – 16:00 – Coffee break
Session 4 : Artificial Intelligence in Pharma
- 16:00 – 16:30 – Dimitrios Meimaroglou, LRGP
« Addressing the challenges of molecular property prediction from a Machine Learning perspective »
Closing session
- 16:30 – 17:30 – Edith Lecomte & Flavien Susanne round table
«The Future of Pharmaceutical Industry»
Exchange with the audience
Final conclusion
Committee
President
Jean-Pierre Dal Pont, SECF
ORGANISING COMMITTEE
- UL PROPULS
- Université de Lorraine
SCIENTIFIC COMMITTEE
- Flavien Susanne, AstraZeneca
- Michael Luescher, Novartis
- Michelangelo Canzoneri, Merck
- Isabelle Chevalot, ENSAIA-UL-LRGP-CNRS
- Laurence Muhr, ENSIC-UL-LRGP-CNRS
- Edith Lecomte, IPSOMEDIC
Key information
When?
July 1-2, 2025
Where?
ENSIC, Université de Lorraine in Nancy (France)
Address: 1 rue Grandville, 54000 Nancy
Organized by
Sponsoring and support
